According to uniQure's latest financial reports and stock price the company's current number of shares outstanding is 48,384,510. At the end of 2024 the company had 48,384,510 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 48.38 M | 1.29% |
2023 | 47.77 M | 2.13% |
2022 | 46.77 M | 1.34% |
2021 | 46.15 M | 3.78% |
2020 | 44.47 M | 9.16% |
2019 | 40.73 M | 9.37% |
2018 | 37.24 M | 45.31% |
2017 | 25.63 M | 1.95% |
2016 | 25.14 M | 4.94% |
2015 | 23.96 M | 34.89% |
2014 | 17.76 M | 0.95% |
2013 | 17.59 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Amgen AMGN | 536,000,000 | 1,007.79% | ๐บ๐ธ USA |
Sanofi SNY | 2,497,600,000 | 5,061.98% | ๐ซ๐ท France |
Sangamo Therapeutics
SGMO | 180,342,000 | 272.73% | ๐บ๐ธ USA |
bluebird bio
BLUE | 109,098,000 | 125.48% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,866,000 | 290.34% | ๐บ๐ธ USA |
Avidity Biosciences RNA | 87,212,000 | 80.25% | ๐บ๐ธ USA |